Date & Time

Monday, 14 Jan

15:00 - 16:00


Main Stage


This presentation will look at the story behind the tsunami of myopia afflicting the global population and what eye care professionals might do to reduce the real risks of vision loss. The surge in myopia, especially high myopia, has real implications for the practice of optometry in the coming decades. Ortho-k and atropine drops show promise in reducing myopia progression and the talk will include the latest therapeutics data.

A recent analysis published in the American Academy of Ophthalmology estimated that 399 million people will have myopia by 2020 - which is 5.2% of the global population. By 2050, however, this figure is set to triple to an astonishing 938 million - roughly 10% of the global population. That's a billion people running the very real risk of blindness. Long story short, myopia could soon replace age-related macular degeneration as the leading cause of blindness.

Learning objectives

Be able to explain to patients about myopia management options

Understand the latest clinical research relating to myopia management


Share Seminar